Simioni Nicolas, Preda Cristian, Deken Valérie, Bence Camille, Cottencin Olivier, Rolland Benjamin
CHU Lille, Département de Psychiatrie et d'Addictologie, Lille, France Etablissement Public de Santé Mentale, Val de Lys - Artois, Centre de Soins d'Accompagnement et de Prévention en Addictologie, Béthune, France
Univ. Lille, CHU Lille, EA 2694 - Santé publique : épidémiologie et qualité des soins, Lille, France.
Alcohol Alcohol. 2016 Nov;51(6):664-669. doi: 10.1093/alcalc/agw011. Epub 2016 Mar 17.
To characterize the profile of patients seeking baclofen treatment for alcohol dependence in France.
We compared retrospectively baclofen seekers and baclofen non-seekers within a cohort of consecutive outpatients with alcohol dependence who attended a first appointment for alcohol treatment at two French addiction centres between September 2012 and March 2014. We documented socio-demographic characteristics; comorbid psychiatric, addiction, alcohol dependence features; patients' initial drinking goal, and referral status; and treatment retention at 6 and 12 months.
Of the 289 patients identified, 107 were baclofen seekers and 182 were baclofen non-seekers. The only parameters significantly associated with baclofen seekers in multivariate analyses were a greater baseline alcohol consumption (β = 15.4, 95% CI: 0.18-30.65, P = 0.05), a controlled-drinking initial goal (OR = 14.9, 95% CI: 7.7-29, P < 0.0001) and self-referral (OR = 6.6, 95% CI: 3.7-12, P < 0.0001), baclofen seekers being eight times more likely to be self-referred and treatment-naïve (OR = 8.8, 95% CI: 4.1-18.9, P < 0.0001). Baclofen seekers were more likely to be retained in treatment at 6 months (OR = 3.5, 95% CI: 1.8-6.7, P < 0.0001) and 12 months (OR = 1.9, 95% CI: 1.1-3.2, P = 0.019).
In France, the perspective of controlled drinking offered by baclofen treatment may have attracted more self-referred patients, including those without previous alcohol treatment, to attend treatment, than the usual treatment options. These findings raise the question as to whether future public health strategies on alcohol should more prominently promote some aspects of alcohol treatment, such as patient's preference and treatment options, in order to reduce the treatment gap in alcohol dependence.
描述在法国寻求巴氯芬治疗酒精依赖的患者特征。
我们对2012年9月至2014年3月期间在法国两家成瘾治疗中心首次就诊接受酒精治疗的连续酒精依赖门诊患者队列中的巴氯芬寻求者和非巴氯芬寻求者进行了回顾性比较。我们记录了社会人口学特征;共病的精神疾病、成瘾、酒精依赖特征;患者的初始饮酒目标和转诊状态;以及6个月和12个月时的治疗留存情况。
在289名确定的患者中,107名是巴氯芬寻求者,182名是非巴氯芬寻求者。多变量分析中与巴氯芬寻求者显著相关的唯一参数是基线酒精消费量更高(β = 15.4,95%置信区间:0.18 - 30.65,P = 0.05)、控制饮酒的初始目标(比值比 = 14.9,95%置信区间:7.7 - 29,P < 0.0001)和自我转诊(比值比 = 6.